Literature DB >> 9846504

Expression of cyclooxygenase-2 protein in gastric adenocarcinoma.

K Uefuji1, T Ichikura, H Mochizuki, N Shinomiya.   

Abstract

BACKGROUND AND OBJECTIVES: Epidemiological studies have suggested that the regular use of nonsteroidal antiinflammatory drugs, which inhibit cyclooxygenase (COX), reduces the risk of colon cancer. The inducible COX-2 isoform has been reported to be upregulated in colorectal carcinomas and may play a role in colorectal carcinogenesis. The purpose of this study was to investigate the expression of COX-2 protein in human gastric adenocarcinomas.
METHODS: COX-2 protein expression was examined in 23 patients with gastric adenocarcinoma by immunoblotting and immunohistochemistry.
RESULTS: There was an increase in COX-2 protein levels in 19 of the 23 carcinomas (83%) compared with the paired normal gastric mucosa by an immunoblot analysis. There was no correlation between tumor histology and COX-2 protein expression. An immunohistochemical study in the 19 cases showed diffuse COX-2 staining in the cytoplasm of cancer cells. Mononuclear cells or fibroblasts of the cancer stroma were not stained with COX-2. Sporadic staining for COX-2 was observed in the normal fundic or metaplastic glandular cells in all cases.
CONCLUSIONS: COX-2 protein expression was elevated in most human gastric adenocarcinomas in comparison to the normal mucosa. COX-2 may therefore play an important role in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846504     DOI: 10.1002/(sici)1096-9098(199811)69:3<168::aid-jso9>3.0.co;2-0

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

1.  Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma.

Authors:  Hong-Xia Li; Xin-Ming Chang; Zheng-Jun Song; Shui-Xiang He
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication.

Authors:  Gulam Waris; Aleem Siddiqui
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Expression of cyclooxygenase-2 protein in colorectal carcinomas.

Authors:  Young-Eun Joo; Hyun-Soo Kim; Sang-Woon Min; Wan-Sik Lee; Chang-Hwan Park; Chang-Soo Park; Sung-Kyu Choi; Jong-Sun Rew; Sei-Jong Kim
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis.

Authors:  Ji-Ren Yu; Yi-Jun Wu; Qi Qin; Ke-Zheng Lu; Sheng Yan; Xiao-Sun Liu; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

5.  Systemic activation of K-ras rapidly induces gastric hyperplasia and metaplasia in mice.

Authors:  Smita S Matkar; Amy Durham; Angela Brice; Timothy C Wang; Anil K Rustgi; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-04-01       Impact factor: 6.166

Review 6.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

7.  Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis.

Authors:  Wei-Hao Sun; Qian Yu; Hong Shen; Xi-Long Ou; Da-Zhong Cao; Ting Yu; Cheng Qian; Feng Zhu; Yun-Liang Sun; Xi-Ling Fu; Han Su
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

8.  Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

9.  Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.

Authors:  Hai Shi; Jian-Ming Xu; Nai-Zhong Hu; Hui-Jun Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2.

Authors:  Kai-Wen Hsu; Rong-Hong Hsieh; Chew-Wun Wu; Chin-Wen Chi; Yan-Hwa Wu Lee; Min-Liang Kuo; Kou-Juey Wu; Tien-Shun Yeh
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.